Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22995619 | 0.85 | — | — | |
| SCHEMBL28081538 | 0.83 | — | — | |
| Methane SCHEMBL10783711 | 0.81 | FDPS (0.43) | FDPSBLMTDP1 | |
| SCHEMBL4119065 | 0.80 | — | — | |
| SCHEMBL11972053 | 0.79 | TSHR (0.42) | TDP1 | |
| Phosphine SCHEMBL28937317 | 0.78 | — | — | |
| SCHEMBL9322637 | 0.78 | — | — | |
| SCHEMBL28264931 | 0.78 | — | — | |
| SCHEMBL15264077 | 0.75 | MMP1 (0.32) | — | |
| SCHEMBL16597718 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037027-A | Modified vinyl alcohol resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-119242376-B | Regeneration treatment method for aluminum alloy cutting waste liquid | 威海万丰镁业科技发展有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-118307587-A | 4-Nitrophenyl disodium phosphate and preparation method thereof | 苏州昊帆生物股份有限公司 | 2024-07-09 | — | — | CN | claimed |
| US-12595433-B2 | Organic phosphorus compound, preparation method therefor, and uses thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2026-04-07 | — | — | US | disclosed |
| CN-119242376-B | Regeneration treatment method for aluminum alloy cutting waste liquid | 威海万丰镁业科技发展有限公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-119431323-A | Heterobicyclic amides as CD38 inhibitors | 贝林格尔·英格海姆国际有限公司 | 2025-02-14 | — | — | CN | disclosed |
| US-20250034476-A1 | ORGANIC PHOSPHORUS COMPOUND, PREPARATION METHOD THEREFOR, AND USES THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2025-01-30 | — | — | US | disclosed |
| CN-119242376-A | Regeneration treatment method for aluminum alloy cutting waste liquid | 威海万丰镁业科技发展有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-118307587-A | 4-Nitrophenyl disodium phosphate and preparation method thereof | 苏州昊帆生物股份有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-111057102-B | Organophosphorus compounds, preparation method and application thereof | 中国石油化工股份有限公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-113512452-B | Diesel engine lubricating oil composition and preparation method thereof | 中国石油化工股份有限公司 | 2023-10-10 | — | — | CN | disclosed |
| CN-111057110-A | Phosphoramidate compound and preparation method and application thereof | 中国石油化工股份有限公司 | 2020-04-24 | — | — | CN | disclosed |
| EP-1032584-B1 | NOVEL 19-NOR STEROIDS SUBSTITUTED IN POSITION 11BETA, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | AVENTIS PHARMA SA (FR) | 2003-02-12 | — | — | EP | disclosed |
| EP-0973793-B1 | NOVEL 4- HALOGENATED STEROIDS, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | AVENTIS PHARMA SA (FR) | 2002-07-10 | — | — | EP | disclosed |
| EP-1032584-A1 | NOVEL 19-NOR STEROIDS SUBSTITUTED IN POSITION 11BETA, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | HOECHST MARION ROUSSEL (FR) | 2000-09-06 | — | — | EP | disclosed |
| EP-0973793-A1 | NOVEL 4- HALOGENATED STEROIDS, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | HOECHST MARION ROUSSEL (FR) | 2000-01-26 | — | — | EP | disclosed |
| WO-1999025725-A1 | NOVEL 19-NOR STEROIDS SUBSTITUTED IN POSITION 11β, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | HOECHST MARION ROUSSEL (FR) | 1999-05-27 | — | — | WO | disclosed |
| WO-1998045316-A1 | NOVEL 4- HALOGENATED STEROIDS, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | HOECHST MARION ROUSSEL (FR) | 1998-10-15 | — | — | WO | disclosed |
| US-4353893-A | BACTERICIDES | KOWA COMPANY, LTD. (JP) | 1982-10-12 | — | — | US | disclosed |
| EP-0040764-A1 | Novel aminoglycosides, and antibiotic use thereof | KOWA COMPANY, LTD. (JP) | 1981-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595433-B2 | Organic phosphorus compound, preparation method therefor, and uses thereof | NOTUM, GC, PHOSPHO1 | CA2 821/4885FDPS 1006/4885BLM 2022/4885 |
| US-20250034476-A1 | ORGANIC PHOSPHORUS COMPOUND, PREPARATION METHOD THEREFOR, AND USES THEREOF | SOST, NOTUM, WEE1 | CA2 1742/4885FDPS 346/4885BLM 1133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.